Education
About Us
Working with TipRanks
Follow Us
4DMedical Ltd (AU:4DX)
:4DX
4DX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.23 - AU$0.72
Previous CloseN/A
Volume497.15K
Average Volume (3M)1.12M
Market Cap
AU$117.11M
Enterprise ValueAU$187.92M
Total Cash (Recent Filing)AU$3.09M
Total Debt (Recent Filing)AU$3.00M
Price to Earnings (P/E)―
Beta1.43
Next Earnings
Aug 28, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding450,419,070
10 Day Avg. Volume1,367,541
30 Day Avg. Volume1,116,434
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)190.51
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.85Price Target Upside240.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
4DMedical Ltd News
PremiumCompany Announcements
4DMedical Expands Industry Partnerships and Gains Congressional Recognition
PremiumCompany Announcements
4DMedical Implements Cost Reduction Program to Enhance Financial Stability
PremiumCompany Announcements
4DMedical Ltd Announces New Options Issuance to Boost Market PresencePremiumCompany Announcements
4DMedical Ltd Announces Strategic Options Offers
PremiumCompany Announcements
4DMedical Secures $13.9 Million to Boost Lung Diagnostics Commercialization
PremiumCompany Announcements
4DMedical Announces Cessation of Securities
PremiumCompany Announcements
4DMedical Announces Change in Director’s Interest---
Options Prices
Currently, No data available
---
Ownership Overview
0.84% Insiders
―
Mutual Funds
― Other Institutional Investors
99.15% Public Companies and
Individual Investors
4DX FAQ
What was 4DMedical Ltd’s price range in the past 12 months?
4DMedical Ltd lowest share price was AU$0.23 and its highest was AU$0.71 in the past 12 months.
What is 4DMedical Ltd’s market cap?
4DMedical Ltd’s market cap is AU$117.11M.
When is 4DMedical Ltd’s upcoming earnings report date?
4DMedical Ltd’s upcoming earnings report date is Aug 28, 2025 which is in 138 days.
How were 4DMedical Ltd’s earnings last quarter?
4DMedical Ltd released its earnings results on Feb 27, 2025. The company reported -AU$0.025 earnings per share for the quarter, beating the consensus estimate of -AU$0.04 by AU$0.015.
Is 4DMedical Ltd overvalued?
According to Wall Street analysts 4DMedical Ltd’s price is currently Undervalued.
Does 4DMedical Ltd pay dividends?
4DMedical Ltd does not currently pay dividends.
What is 4DMedical Ltd’s EPS estimate?
4DMedical Ltd’s EPS estimate is -0.04.
How many shares outstanding does 4DMedical Ltd have?
4DMedical Ltd has 450,419,070 shares outstanding.
What happened to 4DMedical Ltd’s price movement after its last earnings report?
4DMedical Ltd reported an EPS of -AU$0.025 in its last earnings report, beating expectations of -AU$0.04. Following the earnings report the stock price went down -7.317%.
Which hedge fund is a major shareholder of 4DMedical Ltd?
Currently, no hedge funds are holding shares in AU:4DX
---
4DMedical Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.85 (240.00% Upside)
AU$0.85 (240.00% Upside)
Blogger Sentiment
Bullish
AU:4DX Sentiment 70%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.53%
12-Months-Change
Fundamentals
Return on Equity
-52.37%
Trailing 12-Months
Asset Growth
-29.03%
Trailing 12-Months
Company Description
4DMedical Ltd
4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.
---
4DX Stock 12 Month Forecast
Average Price Target
AU$0.85
▲(240.00% Upside)
Technical Analysis
Cochlear Limited
―
CSL
―
Nanosonics Limited
―
Resonance Health Ltd
―
Race Oncology Ltd.
―
Best Analysts Covering 4DX
1 Year
1 Year Success Rate
3/7 ratings generated profit
1 Year Average Return
-4.99%
reiterated a buy rating 2 months ago
Copying John Hester's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -4.99% per trade.
---